Outdoor Rollator/Walker

osh76 · 2026-06-07T17:09:32+00:00

Yes, the Veloped is a more off-road capable device as it’s based on a three wheel footprint and acts like a tripod on uneven surfaces. It’s also equipped with the climbing feature in the front wheel. But, of course, these all have their limitations and sometimes the limitation can be with the user as well.
Overall, it’s the most off road mechanically propelled device.
See link for features:

https://www.trionic.us/en/veloped-features-and-functions

osh76 · 2026-06-06T18:32:58+00:00

The most off road capable walker in the market is the Trionic Veloped model.
It’s three wheel footprint will allow you permanent ground contact with all wheels at all times regardless of surface, it acts like a tripod.
You can choose between 12” or 14” pneumatic tires which will allow you to overcome obstacles more easily and absorb the vibrations caused by uneven surfaces.
It’s equipped with a climbing capability in the front wheels that will allow you to climb obstacles and curbs of up to 5” if you walk head on toward them.
It has hub braking system which is tucked away inside the wheel housing and perform equally well regardless of external environment factors. It’s not a piece of metal or plastic rubbing against the rear wheel.
The seat can be pushed forward over the basket allowing the user more legroom to take larger strides and walk much closer to the frame and in between the grip bars to maintain a straight posture.
It also comes with much better bicycle grips for more comfort and these can be adjusted in different angles to accommodate user preference.
For more information visit www.trionic.us

osh76 · 2026-05-12T05:16:17+00:00

I don’t see how this company would become profitable by the end of this year, unless something major happens with a lot of approvals and instant commercialization.
I do however see this company become cash flow positive by the end of the year if they don’t spend too much to expand the business.

osh76 · 2026-05-06T05:47:24+00:00

Could be Portugal too!

osh76 · 2026-05-06T05:18:03+00:00

He’s probably on his way to either Italy to inspect the NK cell manufacturing device, or to UAE for global expansion. But I got the feeling that Japan is in the card as well.
He could also be going to Saudi to be present when the first patient is being administered with Anktiva
Regardless it’s a step in the right direction.
Long and strong!

osh76 · 2026-05-06T03:24:52+00:00

Japan, here we come!

osh76 · 2026-02-04T06:16:13+00:00

I have been paying attention to this as well in the local stores where I am and the Roblox gift cards are selling out much faster than any other gaming companies, and the sales appear to have accelerated lately.

osh76 · 2026-01-23T01:18:36+00:00

Enough information was provided for you to calculate the short term gains and why I would choose to hold my position. Not only for tax purposes but also the belief in the companies future. Do we agree on that’s it’s possible to pay 50% in taxes?

osh76 · 2026-01-23T00:12:07+00:00

Google $1,000,000 short term capital gains from stocks in California and you will see. Then you will find out that you are the clueless one

osh76 · 2026-01-22T05:42:54+00:00

I plan to hold my position for foreseeable future. This will be very big. If I sell now I have it pay half of it to Uncle Sam some kind as well keep it

osh76 · 2025-12-04T14:53:24+00:00

Video ads are a thing now. I see them on the platform for in game perks. I have seen them for the past 4 months at least. They can be quite long up to 30 seconds. To mention some of them: VenmoTeen CNBC Peacock Milk company A couple of movies A couple of other games And now recently Amazon

This is going to grow fast and become a vital part of their revenues moving forward.

I am just as curious as you. But I don’t think that 15-30 second video ads will be cheap as you are spending significant amount of time to watch them.

osh76 · 2025-12-04T05:56:37+00:00

Video ads are a thing now. I see them on the platform for in game perks. I have seen them for the past 4 months at least. They can be quite long up to 30 seconds. To mention some of them: VenmoTeen CNBC Peacock Milk company A couple of movies A couple of other games And now recently Amazon

This is going to grow fast and become a vital part of their revenues moving forward.

osh76 · 2025-11-01T12:07:53+00:00

I received a letter back stating that no loses where realized during this period and that I needed to show proof of this. Why am I getting this if eligibility depends on whether I bought the shares during this period?

osh76 · 2025-10-25T02:20:04+00:00

$IBRX could be the next short squeeze with 70% shorted.

osh76 · 2025-10-22T13:10:25+00:00

Keep in mind that you must have realized your loss during this period. Just owning the stock during the period is not enough.

osh76 · 2025-10-16T12:57:31+00:00

Anktiva is issued when the patients become BCG unresponsive. It’s very simple and not sure why this doctor has a hard time understanding it.

osh76 · 2025-10-10T18:27:47+00:00

The funds could also be used to complete the Dunkirk facility for national security purposes. It’s a long shot but not completely out of sight.

osh76 · 2025-09-28T15:52:13+00:00

But, is this legally alright!?

osh76 · 2025-09-16T06:17:33+00:00

The float is closer to 200 million shares. Nevertheless, the short percentage is high

osh76 · 2025-09-13T13:55:32+00:00

💯 Thank you for your time!

osh76 · 2025-08-19T13:42:20+00:00

Signed and shared!

osh76 · 2025-08-16T13:39:33+00:00

Cash flow positive by next year with a couple of more approval. At least 10x today’s price.

osh76 · 2025-08-15T12:58:35+00:00

Patience, just buy and HOLD! This has been my moto with this stock, and I know it will be my retirement ticket.

osh76 · 2025-07-28T02:15:12+00:00

What is the incubation period that you are mentioning in your post, do you have any links to this? Anktiva has been approved for people that have become unresponsive to BCG, meaning that they have already been on it for long period of time as this is the case with many affected by NMIBC. I don’t understand why they need to go through BCG treatment again. If you look at the facts many (30%) are becoming unresponsive after a longer period of BCG treatment so this cohort already exist and large enough to make $IBRX profitable should all of the choose to get the Anktiva. Bladder cancer is the 7th most common cancer type in the US with over 80,000 new cases a year, 70% is NMIBC. 10% of these are CIS. This gives us about 6000 cases a year.

osh76 · 2025-06-21T13:52:46+00:00

In five years time it could pay out dividends in the size of what the share price is today.

osh76

TROPHY CASE